Advertisement

Clinical Immunology in Diagnoses of Maxillofacial Disease

  • Nathaniel TreisterEmail author
  • Arturo Saavedra
  • Alessandro Villa
Reference work entry

Abstract

There is an immunological basis for a wide spectrum of oral medicine conditions, ranging from autoimmunity to infection. While patient history and physical examination serve as the cornerstones for clinical diagnosis, in many situations additional laboratory testing is necessary in order to arrive at a definitive diagnosis. As such, a comprehensive understanding of clinical immunology and its relevance to the pathogenesis and diagnosis of oral medicine conditions is essential. This chapter provides an overview of the immune system, indications for immunological work-up, a summary of clinical immunology tests relevant to the practice of oral medicine, and a discussion of the oral medicine conditions for which clinical immunological testing may be indicated.

Keywords

ELISA Immunoblotting Immunofluorescence Antibody titer analysis Connective tissue disease Serology Allergy testing Prick testing Patch testing Histopathology Oral immunology Oral vesiculobullous disorders 

References

  1. Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013;126(4):342–8.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Abraham RS. Relevance of antibody testing in patients with recurrent infections. J Allergy Clin Immunol. 2012;130(2):558–9. e6PubMedCrossRefPubMedCentralGoogle Scholar
  3. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford). 2009;48(Suppl 3):iii3–7.Google Scholar
  4. Aggarwal A. Role of autoantibody testing. Best Pract Res Clin Rheumatol. 2014;28(6):907–20.PubMedCrossRefPubMedCentralGoogle Scholar
  5. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2014;73(1):17–23.PubMedCrossRefPubMedCentralGoogle Scholar
  6. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 Suppl):S51–131.PubMedCrossRefPubMedCentralGoogle Scholar
  7. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl:S25):e1–12.Google Scholar
  8. Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121:4036.PubMedPubMedCentralCrossRefGoogle Scholar
  9. American College of Rheumatology Position Statement: Methodology of Testing for Antinuclear Antibodies. https://www.rheumatology.org/Portals/0/Files/Methodology%20of%20Testing%20Antinuclear%20Antibodies%20Position%20Statement.pdf.
  10. Anderson NW, Buchan BW, Ledeboer NA. Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus. J Clin Microbiol. 2014;52(1):2–8.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect. 2001;77(4):232–7.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Ausukua M, Dublin I, Echebarria MA, Aguirre JM. Oral allergy syndrome (OAS). General and stomatological aspects. Med Oral Patol Oral Cir Bucal. 2009;14(11):e568–72.PubMedCrossRefPubMedCentralGoogle Scholar
  13. Aydemir S, Tekin NS, Aktunc E, Numanoglu G, Ustundag Y. Celiac disease in patients having recurrent aphthous stomatitis. Turk J Gastroenterol. 2004;15(3):192–5.PubMedPubMedCentralGoogle Scholar
  14. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–605.PubMedCrossRefPubMedCentralGoogle Scholar
  15. Bhagat M, Sehra ST, Shahane A, Kwan M. Utility of immunologic testing in suspected rheumatologic disease. Curr Allergy Asthma Rep. 2014;14(1):405.PubMedCrossRefPubMedCentralGoogle Scholar
  16. Bhol KC, Ahmed AR. Production of non-pathogenic human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient. Autoimmunity. 2002;35(2):87–91.PubMedCrossRefPubMedCentralGoogle Scholar
  17. Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S33–40.PubMedCrossRefPubMedCentralGoogle Scholar
  18. Burnside RD. 22q11.21 deletion syndromes: a review of proximal, central, and distal deletions and their associated features. Cytogenet Genome Res. 2015;146(2):89–99.PubMedCrossRefPubMedCentralGoogle Scholar
  19. Caprioli F, Marafini I, Facciotti F, Pallone F, Monteleone G. Targeting T cells in chronic inflammatory bowel diseases. J Clin Cell Immunol. 2013;4:1–6.CrossRefGoogle Scholar
  20. Chan EL, Brandt K, Horsman GB. Comparison of Chemicon SimulFluor direct fluorescent antibody staining with cell culture and shell vial direct immunoperoxidase staining for detection of herpes simplex virus and with cytospin direct immunofluorescence staining for detection of varicella-zoster virus. Clin Diagn Lab Immunol. 2001;8(5):909–12.PubMedPubMedCentralGoogle Scholar
  21. Cottom H, Mighell AJ, High A, Bateman AC. Are plasma cell-rich inflammatory conditions of the oral mucosa manifestations of IgG4-related disease? J Clin Pathol. 2015;68(10):802–7.PubMedCrossRefPubMedCentralGoogle Scholar
  22. Cummins DL, Mimouni D, Tzu J, Owens N, Anhalt GJ, Meyerle JH. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol. 2007;56(1):153–9.PubMedCrossRefPubMedCentralGoogle Scholar
  23. Dahl H, Marcoccia J, Linde A. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol. 1997;35(2):347–9.PubMedPubMedCentralGoogle Scholar
  24. Dawes C, Pedersen AM, Villa A, Ekstrom J, Proctor GB, Vissink A, et al. The functions of human saliva: a review sponsored by the World workshop on oral medicine VI. Arch Oral Biol. 2015;60(6):863–74.PubMedCrossRefPubMedCentralGoogle Scholar
  25. D'Cruz D. Testing for autoimmunity in humans. Toxicol Lett. 2002;127(1–3):93–100.PubMedCrossRefPubMedCentralGoogle Scholar
  26. De Marie S. Diseases and drug-related interventions affecting host defence. Eur J Clin Microbiol Infect Dis. 1993;12(Suppl 1):S36–41.PubMedCrossRefPubMedCentralGoogle Scholar
  27. De Rossi SS, Ciarrocca K. Oral lichen planus and lichenoid mucositis. Dent Clin N Am. 2014;58(2):299–313.PubMedCrossRefPubMedCentralGoogle Scholar
  28. Dreborg S, Foucard T. Allergy to apple, carrot and potato in children with birch pollen allergy. Allergy. 1983;38(3):167–72.PubMedCrossRefPubMedCentralGoogle Scholar
  29. Dropulic LK, Cohen JI. Severe viral infections and primary immunodeficiencies. Clin Infect Dis. 2011;53(9):897–909.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34–50.PubMedCrossRefPubMedCentralGoogle Scholar
  31. Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations. Medicine (Baltimore). 2003;82(3):177–86.Google Scholar
  32. Elliott K, McQuaid S, Salto-Tellez M, Maxwell P. Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics. J Clin Pathol. 2015;68(10):766–70.PubMedCrossRefPubMedCentralGoogle Scholar
  33. Farkas H, Veszeli N, Kajdacsi E, Cervenak L, Varga L. “Nuts and Bolts” of Laboratory Evaluation of Angioedema. Clin Rev Allergy Immunol. 2016;51:140–51.PubMedCrossRefPubMedCentralGoogle Scholar
  34. Feller L, Altini M, Khammissa RA, Chandran R, Bouckaert M, Lemmer J. Oral mucosal immunity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):576–83.PubMedCrossRefPubMedCentralGoogle Scholar
  35. Ferri C, Bernini L, Cecchetti R, Latorraca A, Marotta G, Pasero G, et al. Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol. 1991;18(12):1826–32.PubMedPubMedCentralGoogle Scholar
  36. Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005;38(1):55–63.PubMedCrossRefPubMedCentralGoogle Scholar
  37. Franch A, Soriano YJ, Sarrion Perez MG. Dental management of patients with inflammatory bowel disease. J Clin Exp Dent. 2010;2:191–5.CrossRefGoogle Scholar
  38. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn’s disease: NOD2, autophagy and ER stress converge. Gut. 2011;60(11):1580–8.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003;124(1):186–95.PubMedCrossRefPubMedCentralGoogle Scholar
  40. Habash-Bseiso DE, Yale SH, Glurich I, Goldberg JW. Serologic testing in connective tissue diseases. Clin Med Res. 2005;3(3):190–3.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Hayashi T. Dysfunction of lacrimal and salivary glands in Sjogren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model. J Biomed Biotechnol. 2011;2011:407031.PubMedPubMedCentralCrossRefGoogle Scholar
  42. Hepburn A, Charles P. Antinuclear Factor. Rheumatology (Oxford). 2002;41(3):343–345.PubMedCrossRefPubMedCentralGoogle Scholar
  43. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5(2):80–93.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27(1):89–99.PubMedCrossRefPubMedCentralGoogle Scholar
  45. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–65.PubMedCrossRefPubMedCentralGoogle Scholar
  46. Ion D, Stevenson K, Woo SB, Ho VT, Soiffer R, Antin JH, et al. Characterization of oral involvement in acute graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(11):1717–21.PubMedCrossRefPubMedCentralGoogle Scholar
  47. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401. e1PubMedPubMedCentralCrossRefGoogle Scholar
  48. Kalfa VC, Roberts RL, Stiehm ER. The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency. Ann Allergy Asthma Immunol. 2003;90(2):259–64.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Kampgen E, Burg G, Wank R. Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol. 1988;124(9):1372–5.PubMedCrossRefPubMedCentralGoogle Scholar
  50. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134(5):743–56.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Kerr DA, McClatchey KD, Regezi JA. Allergic gingivostomatitis (due to gum chewing). J Periodontol. 1971;42(11):709–12.PubMedCrossRefPubMedCentralGoogle Scholar
  52. Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. J German Soc Dermatol. 2011;9(11):927–47.Google Scholar
  53. Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol. 2013;19(46):8571–9.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Lee SJ. New approaches for preventing and treating chronic graft-versus-host disease. Blood. 2005;105(11):4200–6.PubMedPubMedCentralCrossRefGoogle Scholar
  55. LeGoff J, Pere H, Belec L. Diagnosis of genital herpes simplex virus infection in the clinical laboratory. Virol J. 2014;11:83.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Loke WS, Herbert C, Thomas PS. Sarcoidosis: immunopathogenesis and immunological markers. Int J Chronic Dis. 2013;2013:928601.PubMedPubMedCentralGoogle Scholar
  57. Lonial S, Durie B, Palumbo A, San-Miguel J. Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives. Leukemia. 2016;30(3):526–35.PubMedCrossRefPubMedCentralGoogle Scholar
  58. Maeno N, Takei S, Imanaka H, Oda H, Yanagi K, Hayashi Y, et al. Anti-alpha-fodrin antibodies in Sjogren’s syndrome in children. J Rheumatol. 2001;28(4):860–4.PubMedPubMedCentralGoogle Scholar
  59. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519–31.PubMedCrossRefPubMedCentralGoogle Scholar
  60. Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134(3):679–87.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol. 2009;75(6):579–82.PubMedCrossRefPubMedCentralGoogle Scholar
  62. Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity. 2005;38(1):47–54.PubMedCrossRefPubMedCentralGoogle Scholar
  63. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;11(3):462–81.PubMedPubMedCentralCrossRefGoogle Scholar
  64. Mokhtarifar A, Ganji A, Sadrneshin M, Bahari A, Esmaeilzadeh A, Ghafarzadegan K, et al. Diagnostic value of ASCA and atypical p-ANCA in differential diagnosis of inflammatory bowel disease. Middle East J Dig Dis. 2013;5(2):93–7.PubMedPubMedCentralGoogle Scholar
  65. Mowad CM, Anderson B, Scheinman P, Pootongkam S, Nedorost S, Brod B. Allergic contact dermatitis: patient management and education. J Am Acad Dermatol. 2016;74(6):1043–54.PubMedCrossRefPubMedCentralGoogle Scholar
  66. Nelson JL. Microchimerism and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol. 1998;10(6):564–71.PubMedCrossRefPubMedCentralGoogle Scholar
  67. Ortolani C, Ispano M, Pastorello E, Bigi A, Ansaloni R. The oral allergy syndrome. Ann Allergy. 1988;61(6 Pt 2):47–52.PubMedPubMedCentralGoogle Scholar
  68. Ortolani C, Ispano M, Pastorello EA, Ansaloni R, Magri GC. Comparison of results of skin prick tests (with fresh foods and commercial food extracts) and RAST in 100 patients with oral allergy syndrome. J Allergy Clin Immunol. 1989;83(3):683–90.PubMedCrossRefPubMedCentralGoogle Scholar
  69. Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 2000;106(6):1147–54.PubMedCrossRefPubMedCentralGoogle Scholar
  70. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372(9637):489–502.PubMedCrossRefPubMedCentralGoogle Scholar
  71. Perez-Aguilar MC, Goncalves L, Bonfante-Cabarcas R. Adenosine deaminase in severe combined immunodeficiency syndrome. Investig Clin. 2012;53:315–24.Google Scholar
  72. Popescu FD. Cross-reactivity between aeroallergens and food allergens. World J Methodol. 2015;5(2):31–50.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Preeti L, Magesh K, Rajkumar K, Karthik R. Recurrent aphthous stomatitis. J Oral Maxillofac Pathol. 2011;15(3):252–6.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal. 2000;14(1):13–6.PubMedCrossRefPubMedCentralGoogle Scholar
  75. Rodriguez J, Crespo JF, Lopez-Rubio A, De La Cruz-Bertolo J, Ferrando-Vivas P, Vives R, et al. Clinical cross-reactivity among foods of the Rosaceae family. J Allergy Clin Immunol. 2000;106(1 Pt 1):183–9.PubMedCrossRefPubMedCentralGoogle Scholar
  76. Sakaguchi S, Wing K, Miyara M. Regulatory T cells – a brief history and perspective. Eur J Immunol. 2007;37(Suppl 1):S116–23.PubMedCrossRefPubMedCentralGoogle Scholar
  77. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;341(17):1284–91.PubMedCrossRefPubMedCentralGoogle Scholar
  78. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International Consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999;111(4):507–13.PubMedCrossRefPubMedCentralGoogle Scholar
  79. Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, et al. Addendum to the international Consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol. 2003;120(3):312–8.PubMedCrossRefPubMedCentralGoogle Scholar
  80. Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S41–52.PubMedPubMedCentralCrossRefGoogle Scholar
  81. Self SE. Autoantibody testing for autoimmune disease. Clin Chest Med. 2010;31(3):415–22.PubMedCrossRefPubMedCentralGoogle Scholar
  82. Sharfe N, Nahum A, Newell A, Dadi H, Ngan B, Pereira SL, et al. Fatal combined immunodeficiency associated with heterozygous mutation in STAT1. J Allergy Clin Immunol. 2014;133(3):807–17.PubMedCrossRefPubMedCentralGoogle Scholar
  83. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34(2):501–37.PubMedCrossRefPubMedCentralGoogle Scholar
  84. Shiohara T, Moriya N, Nagashima M. Induction and control of lichenoid tissue reactions. Springer Semin Immunopathol. 1992;13(3–4):369–85.PubMedPubMedCentralGoogle Scholar
  85. Singh A, Preiksaitis J, Ferenczy A, Romanowski B. The laboratory diagnosis of herpes simplex virus infections. Can J Infect Dis Med Microbiol. 2005;16(2):92–8.PubMedPubMedCentralCrossRefGoogle Scholar
  86. Sinico RA, Radice A. Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S112–7.PubMedPubMedCentralGoogle Scholar
  87. Smetana GW, Landon BE, Bindman AB, Burstin H, Davis RB, Tjia J, et al. A comparison of outcomes resulting from generalist vs specialist care for a single discrete medical condition: a systematic review and methodologic critique. Arch Intern Med. 2007;167(1):10–20.PubMedCrossRefPubMedCentralGoogle Scholar
  88. Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012;51(8):889–902.PubMedCrossRefPubMedCentralGoogle Scholar
  89. Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N. Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Med Genet. 2011;12:118.PubMedPubMedCentralCrossRefGoogle Scholar
  90. Stinton LM, Fritzler MJ. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev. 2007;7(1):77–84.PubMedCrossRefPubMedCentralGoogle Scholar
  91. Stojanov IJ, Woo SB. Human papillomavirus and Epstein-Barr virus associated conditions of the oral mucosa. Semin Diagn Pathol. 2015;32(1):3–11.PubMedCrossRefPubMedCentralGoogle Scholar
  92. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN, Cheuk W, Cornell L, Castillo CF, Ferry JA, Forcione D, Klöppel G, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Masaki Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani D, Sato Y, Smyrk T, Stone JR, Takahira M, Umehara H, Webster G, Yamamoto M, Yi E, Yoshino T, Zamboni G, Zen Y, Chari S. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–7.PubMedPubMedCentralCrossRefGoogle Scholar
  93. Stukus DR, Mikhail I. Pearls and pitfalls in diagnosing IgE-mediated food allergy. Curr Allergy Asthma Rep. 2016;16(5):34.PubMedCrossRefPubMedCentralGoogle Scholar
  94. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum. 1997;40(9):1601–11.PubMedCrossRefPubMedCentralGoogle Scholar
  95. Teo EC, Chew Y, Phipps C. A review of monoclonal antibody therapies in lymphoma. Crit Rev Oncol Hematol. 2016 Jan;97:72–84.PubMedCrossRefPubMedCentralGoogle Scholar
  96. Turvey SE, Broide DH. Innate immunity. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S24–32.PubMedCrossRefPubMedCentralGoogle Scholar
  97. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54–61.PubMedCrossRefPubMedCentralGoogle Scholar
  98. Virgo PF, Gibbs GJ. Flow cytometry in clinical pathology. Ann Clin Biochem. 2012;49(Pt 1):17–28.PubMedCrossRefPubMedCentralGoogle Scholar
  99. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503–10.PubMedCrossRefPubMedCentralGoogle Scholar
  100. Voehringer D. Protective and pathological roles of mast cells and basophils. Nat Rev Immunol. 2013;13(5):362–75.PubMedCrossRefPubMedCentralGoogle Scholar
  101. Warrington R, Watson W, Kim HL, Antonetti FR. An introduction to immunology and immunopathology. Allergy, Asthma Clin Immunol. 2011;1(7 Suppl):S1.CrossRefGoogle Scholar
  102. Williams V, Gershon A, Brunell PA. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 1974;130(6):669–72.PubMedCrossRefPubMedCentralGoogle Scholar
  103. Woo SB. Oral pathology: a comprehensive atlas and text 2012.Google Scholar
  104. Workowski KA. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(Suppl 8):S759–62.PubMedCrossRefPubMedCentralGoogle Scholar
  105. Yuan A, Woo SB. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(1):35–47.PubMedCrossRefPubMedCentralGoogle Scholar
  106. Zuraw BL, Bernstein JA, Lang DM, Craig T, Dreyfus D, Hsieh F, et al. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2013;131(6):1491–3.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nathaniel Treister
    • 1
    Email author
  • Arturo Saavedra
    • 2
  • Alessandro Villa
    • 1
    • 3
  1. 1.Department of Oral Medicine, Infection and ImmunityHarvard School of Dental MedicineBostonUSA
  2. 2.Department of DermatologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  3. 3.Division of Oral Medicine and DentistryBrigham and Women’s HospitalBostonUSA

Personalised recommendations